CY980A - 3-substituted-morphinan derivatives - Google Patents

3-substituted-morphinan derivatives

Info

Publication number
CY980A
CY980A CY980A CY98072A CY980A CY 980 A CY980 A CY 980A CY 980 A CY980 A CY 980A CY 98072 A CY98072 A CY 98072A CY 980 A CY980 A CY 980A
Authority
CY
Cyprus
Prior art keywords
substituted
morphinan derivatives
morphinan
derivatives
Prior art date
Application number
CY980A
Other languages
English (en)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of CY980A publication Critical patent/CY980A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/36Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/28Morphinans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
CY980A 1971-09-08 1972-09-07 3-substituted-morphinan derivatives CY980A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17883771A 1971-09-08 1971-09-08
US00217633A US3819635A (en) 1971-09-08 1972-01-13 14-hydroxymorphinan derivatives

Publications (1)

Publication Number Publication Date
CY980A true CY980A (en) 1979-03-23

Family

ID=26874723

Family Applications (1)

Application Number Title Priority Date Filing Date
CY980A CY980A (en) 1971-09-08 1972-09-07 3-substituted-morphinan derivatives

Country Status (19)

Country Link
US (1) US3819635A (it)
JP (1) JPS5310596B2 (it)
AU (1) AU470102B2 (it)
BE (1) BE788478A (it)
CA (1) CA999578A (it)
CH (1) CH590845A5 (it)
CY (1) CY980A (it)
DD (1) DD100255A5 (it)
DE (3) DE2265255C2 (it)
DK (1) DK141624B (it)
FR (1) FR2154481B1 (it)
GB (2) GB1412130A (it)
HK (1) HK2679A (it)
IE (2) IE36688B1 (it)
KE (1) KE2911A (it)
MY (1) MY7900027A (it)
NL (1) NL162072C (it)
SE (2) SE398877B (it)
YU (1) YU45099B (it)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910920A (en) * 1973-11-07 1975-10-07 Bristol Myers Co 3,14,17-Substituted-6,7-tetramethylenemorphinans
US3980641A (en) * 1975-07-31 1976-09-14 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinans
US4017497A (en) * 1975-11-18 1977-04-12 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
US4052389A (en) * 1976-03-23 1977-10-04 Bristol-Myers Company Derivatives of 9,10-dihydroxy-1-(p-alkoxybenzyl)-perhydroisoquinoline oxazine-3-one
US4139534A (en) * 1977-02-17 1979-02-13 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
US4058531A (en) * 1976-03-23 1977-11-15 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
JPS52136176A (en) * 1976-03-23 1977-11-14 Bristol Myers Co Method of improving 144hydroxymorphinan derivatives
GB1587831A (en) * 1977-03-23 1981-04-08 Reckitt & Colmann Prod Ltd Morphine derivatives
GB1593191A (en) * 1977-03-23 1981-07-15 Reckitt & Colmann Prod Ltd Derivatives of morphine
US4115389A (en) * 1977-05-02 1978-09-19 Bristol-Myers Company Process of N-demethylating (-)-1-(p-methoxybenzyl)-2-methyl-1,2,3,4,5,6,7,8-octahydroisoquinoline
US4338320A (en) * 1978-11-15 1982-07-06 The Board Of Regents Of The University Of Nebraska Esters of 6'-hydroxycinchonine, and a method of treating arrythmia with them
US4228285A (en) * 1979-02-28 1980-10-14 Bristol-Myers Company 14-Hydroxy-6-oxamorphinans and 14-hydroxy-6-oxaisomorphinans
US4272540A (en) * 1979-04-24 1981-06-09 Sisa, Incorporated 14-Methoxymorphinan-6-one compounds and therapeutic methods of treating pain and drug dependence with them
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
DE69414085T2 (de) * 1993-07-19 1999-03-18 Toray Industries Wirkstoff zum schutze von gehirnzellen
JP3843456B2 (ja) * 1993-07-23 2006-11-08 東レ株式会社 モルヒナン誘導体および医薬用途
CZ281174B6 (cs) * 1993-08-13 1996-07-17 Galena, A.S. Způsob přípravy 3,14ß-dihydroxy-17-normorfinanu
ATE265846T1 (de) 1998-02-25 2004-05-15 Abbott Lab Butorphanol enthaltende formulierungen mit verzögerter freisetzung
US20040167164A1 (en) * 1998-05-05 2004-08-26 Jose Pozuelo Compositions and methods for treating particular chemical addictions and mental illnesses
US7501433B2 (en) * 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
EP2987788A1 (en) 2002-05-17 2016-02-24 Taiwanj Pharmaceuticals Co., Ltd. Opioid and opioid-like compounds and uses thereof
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
CN103073496B (zh) * 2013-02-18 2015-08-26 苏州立新制药有限公司 右美沙芬的制备方法
JP6464181B2 (ja) 2014-10-14 2019-02-06 久光製薬株式会社 貼付剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3166559A (en) * 1965-01-19 J-lower alkoxy-x-phenyloxy-ix-hydroxy-
GB1028407A (en) * 1962-04-06 1966-05-04 Shionogi & Co Improvements in or relating to morphinan derivatives and their preparation
FR1362540A (fr) * 1963-04-05 1964-06-05 Shionogi & Co Dérivés n substitués du morphinane et leur production

Also Published As

Publication number Publication date
DD100255A5 (it) 1973-09-12
DE2243961A1 (de) 1973-04-05
SE7506292L (sv) 1975-06-02
YU227772A (en) 1982-02-28
GB1412130A (en) 1975-10-29
BE788478A (fr) 1973-03-06
FR2154481A1 (it) 1973-05-11
YU45099B (sh) 1992-07-20
DE2265256C2 (de) 1985-10-24
NL162072C (nl) 1980-04-15
IE36688B1 (en) 1977-02-02
AU4622872A (en) 1974-03-07
DE2265256A1 (de) 1977-01-27
CA999578A (en) 1976-11-09
NL162072B (nl) 1979-11-15
DK141624B (da) 1980-05-12
JPS4834864A (it) 1973-05-22
KE2911A (en) 1979-01-26
AU470102B2 (en) 1976-03-04
DE2243961C2 (it) 1988-07-21
DE2265255C2 (de) 1986-06-05
JPS5310596B2 (it) 1978-04-14
CH590845A5 (it) 1977-08-31
GB1412129A (en) 1975-10-29
IE36687B1 (en) 1977-02-02
IE36687L (en) 1973-03-08
US3819635A (en) 1974-06-25
DK141624C (it) 1980-10-13
FR2154481B1 (it) 1976-04-23
SE403286B (sv) 1978-08-07
MY7900027A (en) 1979-12-31
NL7212176A (it) 1973-03-12
HK2679A (en) 1979-01-19
DE2265255A1 (de) 1977-01-27
SE398877B (sv) 1978-01-23

Similar Documents

Publication Publication Date Title
IL38605A0 (en) P-methane-carboxamide derivatives
IE36079B1 (en) Benzazine derivatives
KE2911A (en) 3-substituted-horphinan derivatives
KE2731A (en) Oxidazolone derivatives
ZA728312B (en) Isiondoline derivatives
JPS5533475A (en) Carbobenzoxydiglycyllllarginyll44methoxyy 22naphthylamide
AU4916772A (en) Benzimidazolyl-2-aminoimidazolines
IL39880A0 (en) 2-nitro-5-imidazolaldehyde derivatives
ZA721334B (en) Novel imidazo-pyridine derivatives
IL38936A0 (en) Lumilysergol derivatives
ZA72165B (en) Substituted m-trifluormethylphenylurea derivatives
YU148272A (en) Zracno hlajeni hladilnik olja
CY908A (en) Triazolyl-ethenyl-phenylene derivatives
GB1408201A (en) Adenosine-5-carboxylate derivatives
AU4209872A (en) Container-agitator
IE37196L (en) Diphenylpyrazolium derivatives
GB1402325A (en) Dibenzoxirenoazepine derivatives
IL39834A (en) Beta-phenyl-beta-fluoroethane derivatives
ZA721356B (en) Benzodiazane derivatives
MY7900211A (en) 2-aminomethylphenol derivatives
GB1401806A (en) Methylene-dioxyquinazoline derivatives
ZA722426B (en) Novel aminophenylketone derivatives
IL39613A0 (en) New dioxo-bicycloalkane derivatives
YU146372A (en) Kabelska sklopka v samodejnim sklopkah tirnih vozil
IE36634B1 (en) 1-pyridylalkyl-indole derivatives